Innoviva Dividends and Buybacks
Dividend criteria checks 0/6
Innoviva does not currently pay a dividend.
Key information
0%
Dividend yield
2.4%
Buyback Yield
| Total Shareholder Yield | 2.4% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €1.000 |
| Payout ratio | 0% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if HVE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HVE's dividend payments have been increasing.
Dividend Yield vs Market
| Innoviva Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (HVE) | 0% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.4% |
| Analyst forecast (HVE) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate HVE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HVE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: HVE is not paying a notable dividend for the German market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as HVE has not reported any payouts.